Skip to content

BBL

by Becton, Dickinson and Company 12 variants

Ref 240958

BBL (240958) is an in vitro diagnostic device (EU IVDR Class B; FDA Class I; FDA product code GTZ, Antisera, All Groups, Streptococcus Spp.; EMDN category streptococcal reagents) made by Becton, Dickinson and Company, registered in EUDAMED on 26 Feb 2026 (Basic UDI-DI 038290GYMSVFYGMT) and listed in FDA GUDID since 25 May 2018 (UDI-DI 00382902409588), active as of 26 Oct 2026.

Active European Union. Also listed in GUDID (US).

CE IVDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 26 Oct 2026.

Regulatory status

as of registry sync 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR EUDAMED Number038290GYMSVFYGMT Basic UDI-DI 00382902409588UDI-DIDate26 Feb 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number00382902409588 UDI-DI Date25 May 2018ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
BD BBL™ Streptocard™ Enzyme Test Latex A, one 2.5 mL bottle
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 30 May 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI 038290GYMSVFYGMT registered 26 Feb 2026 Active
  • FDA GUDID UDI-DI 00382902409588 listed 25 May 2018 Listed

Timeline

2 dated events

  1. Listed FDA GUDID 00382902409588
  2. Registered EUDAMED 038290GYMSVFYGMT

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDR Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
Bbl EUDAMED
BD BBL™ Streptocard™ Enzyme Test Latex A GUDID
Generic name
Beta-haemolytic Streptococcus serological grouping IVD, kit, agglutination
Model / Ref / Catalog
240958
Primary DI / UDI-DI
00382902409588
Basic UDI-DI
038290GYMSVFYGMT
FDA product code
GTZ
EMDN code
W0105011199 Streptococcal reagents - other
GMDN term
Beta-haemolytic Streptococcus serological grouping IVD, kit, agglutination
Device class
Class B EUDAMED
Class I GUDID
Regulation number
866.3740
EU registration type
Standard device
EU market of registration
Belgium
GUDID distribution status
In Commercial Distribution
Size
Total Volume — 2.5 Milliliter

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class B
GUDID
Class I

Device class is stated on each registry's own scale: Class B in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Manufacturer details

EUDAMED SRN
US-MF-000018910
Authorised representative
Becton Dickinson Ireland Limited IE-AR-000007610

Similar devices in this category

Other devices filed under STREPTOCOCCAL REAGENTS - OTHER.

Other devices from Becton, Dickinson and Company

See all devices from Becton, Dickinson and Company →

Properties

  • Single use
  • Contains animal tissues or cells
  • Reagent
  • Professional testing
  • Prescription use
  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (18, all answered No)